Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies

Endocrine Practice

Volumn 10, Issue 5, 2004, Pages 432-437

  Thamprajamchit, Sriurai ^a   Jariengprasert, Chanchai ^a   Rajatanavin, Rajata ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADULT; ARTICLE; AUDIOMETRY; CASE REPORT; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; PERCEPTION DEAFNESS; THYROIDECTOMY; TREATMENT OUTCOME; VASCULITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; AUDIOMETRY; AZATHIOPRINE; FEMALE; GRAVES DISEASE; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROPYLTHIOURACIL; THYROIDECTOMY; TREATMENT OUTCOME; VASCULITIS;

EID: 17144398460     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.10.5.432     Document Type: Article

References (31)

1. Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia: WB Saunders Company, 1998: 389-515.
2. Wing SS, Fantus IG. Adverse immunologic effects of antithyroid drugs. CMAJ. 1987;136:121-127.
3. Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant. 1998;13:455-458.
4. Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophilic cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993;342:651-652.
5. Miller RM, Savige J, Nassis L, Cominos BI. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease. Australas J Dermatol. 1998;39:96-99.
6. Sorribes MM, Welinder NR, Stangerup SE. Anti-neutrophil cytoplasmic antibody associated with mucocutaneous allergic vasculitis with oral manifestations caused by propylthiouracil. J Laryngol Otol. 1999;113:477-479.
7. Helfgott SM, Smith RN. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises: case 21-2002; a 21-year-old man with arthritis during treatment for hyperthyroidism. N Engl J Med. 2002;347:122-130.
8. Smith KE, Spaulding JS. Ototoxic reaction to propylthiouracil. Arch Otolaryngol. 1972;96:368-370.
9. Fong PC, Pun KK, Tai YT, Wang C, Yeung RT. Propylthiouracil hypersensitivity with circumstantial evidence for drug-induced reversible deafness: a case report. Horm Res. 1991;35:132-136.
10. Houston BD, Crouch ME, Brick JE, DiBartolomeo AG. Apparent vasculitis associated with propylthiouracil use. Arthritis Rheum. 1972;22:925-928.
11. Maguchi S, Fukuda S, Chida E, Terayama Y. Myeloperoxidase- antineutrophil cytoplasmic antibodyassociated sensorineural hearing loss. Auris Nasus Larynx. 2001;28(Suppl):S103-S106.
12. D'Cruz D, Chesser AM, Lightowler C, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol. 1995;34:1090-1091.
13. Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol. 1995;20:345-347.
14. Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy [letter]. Nephron. 1996;74:734-735.
15. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophilic cytoplasmic autoantibodypositive glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124:986-988.
16. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis. 1995;26:774-780.
17. Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with antineutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol. 1997;47:336-340.
18. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis; a case report and review of the literature. J Clin Endocrinol Metab. 1999;84: 13-16.
19. Kudoh Y, Kuroda S, Shimamoto K, Iimura O. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol. 1997;48:41-43.
20. Ohtsuka M, Yamashita Y, Doi M, Hasegawa S. Propylthiouracil- induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur Respir J. 1997;10:1405-1407.
21. Yuasa S, Hashimoto M, Yura T, et al. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. Nephron. 1996;73:701-703.
22. Aoki A, Suzuki H, Ohata T, et al. A case of p-ANCA positive necrotizing vasculitis associated with Graves' disease. Ryumachi. 1995;35:683-687.
23. Darben T, Savige J, Prentice R, Paspaliaris B, Chick J. Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil. Australas J Dermatol. 1999;40: 144-146.
24. Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest. 1992;102:1595-1596.
25. Romas E, Henderson DR, Kirkham BW. Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhage [letter]. J Rheumatol. 1995;22:803.
26. Ito K. PTU-induced vasculitis [letter] [in Japanese]. Jpn J Nephrol. 1994;36:1354.
27. Toda A. PTU-induced vasculitis [letter] [in Japanese]. Jpn J Nephrol. 1995;37:701.
28. Hirano K. PTU-induced vasculitis [letter] [in Japanese]. Jpn J Nephrol. 1995;37:701.
29. Saeki T, Miyamura S, Nakano M, Arakawa M. A case of Graves' disease with MPO-ANCA-associated glomerulonephritis during propylthiouracil (PTU) therapy following interstitial pneumonitis [article in Japanese]. Nippon Jinzo Gakkai Shi. 1997;39:167-171.
30. Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab. 2000;85:4270-4273.
31. Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPOANCA and clinical manifestations. Clin Endocrinol (Oxf). 2001;54:651-654.